Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces today that it has expanded its strategic Alliance Agreement with QIAGEN N.V. (HQ: Venlo, The Netherlands; CEO: Thierry Bernard) to deepen their collaboration in genetic testing, including research and development, production, clinical development, and sales-marketing. Sysmex and QIAGEN have built a successful partnership since the initial […]
This joint effort will harness PacBio’s state-of-the-art HiFi sequencing technology to offer profound insights into genetic diversity, disease mechanisms, and clinical diagnoses within Singapore’s multi-ethnic population SINGAPORE — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore (PRECISE) has chosen the Revio HiFi sequencing system for […]
Delivers Illumina’s flagship oncology products on its most powerful sequencers to enable comprehensive genomic profiling at greater scale and at lower overall costs for customers SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has expanded its oncology menu for NovaSeq™ X Series customers. The […]
Singapore’s National Precision Medicine (NPM) programme will sequence 10,000 genomes to improve understanding of genetic architecture and diversity in Singapore’s multi-ethnic Asia population through advanced, nanopore-based sequencing technology Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore’s National Precision Medicine (NPM) programme , led by Precision Health Research, Singapore (PRECISE), aimed at […]
Merck today announced the closing of the transaction to acquire Mirus Bio for approximately US$ 600 million. Advances Merck’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leading GMP transfection reagents complement Merck’s upstream bioprocessing portfolio Combined portfolio meets customer needs as demand for novel modalities grows Darmstadt, Germany […]
Tokyo and Providence, RI – Hitachi High-Tech Corporation (Hitachi High-Tech) and Nabsys 2.0 LLC (Nabsys) announced today that Hitachi High-Tech has acquired a majority interest in Nabsys, a developer and manufacturer of instrumentation and consumables for the analysis of genomic structural variation. This transaction will make Nabsys a consolidated subsidiary of Hitachi High-Tech Group. Hitachi […]
A genetic sequencing project involving 1,500 alpacas from Puno aims to refine the quality and fineness of their fiber. The adoption of genomics in the alpaca industry offers many advantages, such as enhancing the quality of alpaca fiber and promoting the growth of thousands of producers in the highlands. Lima, Peru – In Peru, alpaca fiber […]
Investment in Oxford Nanopore, innovators of a transformational new generation of sensing technology that today specialises in DNA/RNA sequencing £50m to be invested by Novo Holdings as part of an equity issue Novo Holdings intends to make further share purchases over time in the secondary market, subject to availability and price (among other factors) […]
Oxford, UK – Hitachi High-Tech Analytical Science, a Hitachi High-Tech Corporation wholly owned subsidiary engaged in the manufacture and sales of analysis and measuring instruments, has opened a new state-of-the-art applications laboratory in Krefeld, Germany. The new applications laboratory located at the Hitachi High-Tech European head office combines the strengths of Hitachi High-Tech’s core technology […]
Axiom Human Genotyping Arrays Now Integrated with Allelica Polygenic Risk Score Software and Reports
Axiom Human Genotyping Arrays Now Integrated with Allelica Polygenic Risk Score Software and Reports Customers can now use the end-to-end solution to translate research to the clinic to improve disease outcomes in the future. NEW YORK — Allelica, Inc., a leading provider of software tools for polygenic risk scores (PRS), announced a collaboration with Thermo […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
